Lu Zhao

Liraglutide exerts a bone-protective effect in ovariectomized rats with streptozotocin-induced diabetes by inhibiting osteoclastogenesis.

Hongmei Zhao, Xiaochen Wang, B. Wen, 2018, Experimental and therapeutic medicine.

The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis

Wei He, Lu Zhao, W. He, 2022, Drugs.

Effects of sodium‐glucose cotransporter‐2 inhibitors and aldosterone antagonists, in addition to renin‐angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta‐analysis

Lu Zhao, W. He, Shuo Yang, 2022, Diabetes, obesity & metabolism.

Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with kidney outcomes in patients with type 2 diabetes: A systematic review and network meta-analysis

Lu Zhao, W. He, Shuo Yang, 2022, PloS one.

Down-regulation of miR-340-5p promoted osteogenic differentiation through regulation of runt-related transcription factor-2 (RUNX2) in MC3T3-E1 cells

Wei He, Y. Mi, Xiaochen Wang, 2021, Bioengineered.

Liraglutide exerts a bone-protective effect in ovariectomized rats with streptozotocin-induced diabetes by inhibiting osteoclastogenesis.

Hongmei Zhao, Xiaochen Wang, B. Wen, 2018, Experimental and therapeutic medicine.